CompletedNot Applicable

Interest and Impact of Skin Cancer Genetic Testing

United States53 participantsStarted 2016-08

Plain-language summary

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age or older * English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages * Prior history of stage 0, I or II NMSC as per EMR or clinical judgment Exclusion Criteria: * Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician

What they're measuring

number of patients interested in MC1R testing

Timeframe: 1 year

Trial details

NCT IDNCT02941900

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-18

View on ClinicalTrials.gov More Non-melanoma Skin Cancer (NMSC) trials